Bachem Holding AG Bachem Holding AG

Bachem Holding AG

BANB

Kedudukan dalam Saham #2525
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
Harga Saham
$100.24
Modal Pasaran
$7.51B
Perubahan (1 hari)
-1.84%
Perubahan (1 tahun)
48.99%
Negara
CH
Perdagangan Bachem Holding AG (BANB)

Kategori

Healthcare
Sejarah harga saham bagi Bachem Holding AG (BANB)
Harga penutupan tertinggi: $105.12 pada 2026-10-01

Harga penutupan terendah: $13.47 pada 2001-03-01
Sejarah harga saham Bachem Holding AG dari 2001 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) 26.87%
2025 -3.05%
2024 -5.47%
2023 -16.69%
2022 -35.59%
2021 68.81%
2020 169.92%
2019 28.96%
2018 -16.46%
2017 68.14%
2016 64.94%
2015 3.94%
2014 -8.15%
2013 45.10%
2012 -0.04%
2011 -34.01%
2010 -12.09%
2009 -5.58%
2008 -20.36%
2007 13.73%
2006 32.09%
2005 1.28%
2004 12.61%
2003 11.00%
2002 -19.59%
2001 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$535.96 25.68%
US
$186.23 593.59%
US
$137.83 -3.78%
AU
$291.76 2.51%
BE
$892.29 9.59%
NL